YolTech Therapeutics is based in Shanghai, China. It has raised $115M in total funding. Latest round: Series C. Backed by AstraZeneca, CICC.
YolTech Therapeutics is based in Shanghai, China. YolTech Therapeutics has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2026. The round record for YolTech Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include AstraZeneca, CICC. 2 distinct backers are named across the disclosed rounds.
Every YolTech Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026